A series of 113 patients operated on in the period 1980–1989 for a neck recurrence from a head and neck cancer was studied. All patients had no other evidence of disease. The male/female ratio was 93/20, and the median age was 58 years (range 28–87). Previous treatment consisted of surgery (SG) ± radiotherapy (RT) in 81 patients (SG group) and only RT in 32 (RT group): 59 cases presented a relapse in the treated neck and 54 in the contralateral side. All but one contralateral recurrences were in the SG group. Ten patients were lost to followup. The observed 5‐year survival rate of the whole series was 29.2% (95% confidence interval, 0%–38%). Considering patients with ipsilateral recurrences, the 5‐year disease‐free survival rate was 38.7% (95% c.i., 28.7%–48.7%) and 27% (95% c.i., 18%–36%) for the SG and the AT group, respectively. The 5‐year disease‐free survival rate after SG for contralateral recurrences was 38.8% (95% c.i., 23.8%–53.8%). Dimension and mobility of the neck nodes were the only demonstrable prognostic factors.
Salvage surgery of cervical recurrences after neck dissection or radiotherapy / C. Grandi, M. Mingardo, M. Guzzo, L. Licitra, S. Podrecca, R. Molinari. - In: HEAD & NECK. - ISSN 1043-3074. - 15:4(1993 Aug 15), pp. 292-295.
Salvage surgery of cervical recurrences after neck dissection or radiotherapy
L. Licitra;
1993
Abstract
A series of 113 patients operated on in the period 1980–1989 for a neck recurrence from a head and neck cancer was studied. All patients had no other evidence of disease. The male/female ratio was 93/20, and the median age was 58 years (range 28–87). Previous treatment consisted of surgery (SG) ± radiotherapy (RT) in 81 patients (SG group) and only RT in 32 (RT group): 59 cases presented a relapse in the treated neck and 54 in the contralateral side. All but one contralateral recurrences were in the SG group. Ten patients were lost to followup. The observed 5‐year survival rate of the whole series was 29.2% (95% confidence interval, 0%–38%). Considering patients with ipsilateral recurrences, the 5‐year disease‐free survival rate was 38.7% (95% c.i., 28.7%–48.7%) and 27% (95% c.i., 18%–36%) for the SG and the AT group, respectively. The 5‐year disease‐free survival rate after SG for contralateral recurrences was 38.8% (95% c.i., 23.8%–53.8%). Dimension and mobility of the neck nodes were the only demonstrable prognostic factors.File | Dimensione | Formato | |
---|---|---|---|
doi 10_1002 hed_2880150404.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
323.08 kB
Formato
Adobe PDF
|
323.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.